FDA approves Indivior’s long-lasting opioid withdrawal therapy
Monthly injection will help addicts manage withdrawal symptoms
Monthly injection will help addicts manage withdrawal symptoms
Regulator hopes move will combat illegal online trade
Regulator waiting for non-opioid alternatives to reach the market
This could be the end for tozadenant in Parkinson’s disease.
Regulator agrees to restart phase 1 trial of UCART 123
Regulator concerned about unapproved products
BMS’ rival anticoagulant takes commanding market lead.
Diabetes drug has been hit by amputation warning on label.
Fast-acting insulin also approved in US